NUCALA 100 MG/ML SOL INJ CT SER PREENC VD TRANS + ADAPT + AGU

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1010703350024
  • GGREM 510620110056307
  • Código de barras 7896015591991

O que a fonte publica

Detentor do registro
GLAXOSMITHKLINE BRASIL LTDA
Princípios ativos
MEPOLIZUMABE
Embalagem
100 MG/ML SOL INJ CT SER PREENC VD TRANS + ADAPT + AGU
Regime de dispensação
Tarja Vermelha
Tipo de produto
Biológico
Classe terapêutica
R3M - ANTIASMÁTICOS INIBIDORES DA INTERLEUCINA
Prescrição
Sob prescrição ou restrito

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:510620110056307
{
  "name": "NUCALA 100 MG/ML SOL INJ CT SER PREENC VD TRANS + ADAPT + AGU",
  "holder": "GLAXOSMITHKLINE BRASIL LTDA",
  "stripe": "Tarja Vermelha",
  "barcodes": [
    "7896015591991",
    "0000000000000"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "510620110056307",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "33.247.743/0001-10",
  "priceRegime": "Regulado",
  "productName": "NUCALA",
  "productType": "Biológico",
  "hospitalOnly": false,
  "presentation": "100 MG/ML SOL INJ CT SER PREENC VD TRANS + ADAPT + AGU",
  "sourceStatus": null,
  "supplyRegime": "Tarja Vermelha",
  "factoryPrices": {
    "icms-0": "8374.55",
    "icms-12": "9516.54",
    "icms-17": "10089.82",
    "icms-18": "10212.86",
    "icms-19": "10338.95",
    "icms-20": "10468.19",
    "icms-21": "10600.70",
    "icms-22": "10736.60",
    "icms-23": "10876.04",
    "icms-17.5": "10150.97",
    "icms-19.5": "10403.17",
    "icms-20.5": "10534.03",
    "icms-22.5": "10805.87",
    "icms-12-alc": "8496.91",
    "icms-17-alc": "9008.76",
    "icms-18-alc": "9118.63",
    "icms-19-alc": "9231.20",
    "icms-20-alc": "9346.59",
    "icms-21-alc": "9464.91",
    "icms-22-alc": "9586.25",
    "icms-23-alc": "9710.74",
    "withoutTaxes": "7477.28",
    "icms-17.5-alc": "9063.37",
    "icms-19.5-alc": "9288.54",
    "icms-20.5-alc": "9405.37",
    "icms-22.5-alc": "9648.09"
  },
  "pisCofinsList": "Negativa",
  "substanceText": "MEPOLIZUMABE",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "11234.16",
    "icms-12": "12766.10",
    "icms-17": "13535.13",
    "icms-18": "13700.19",
    "icms-19": "13869.33",
    "icms-20": "14042.70",
    "icms-21": "14220.46",
    "icms-22": "14402.77",
    "icms-23": "14589.82",
    "icms-17.5": "13617.16",
    "icms-19.5": "13955.48",
    "icms-20.5": "14131.03",
    "icms-22.5": "14495.69",
    "icms-12-alc": "11746.48",
    "icms-17-alc": "12454.08",
    "icms-18-alc": "12605.97",
    "icms-19-alc": "12761.59",
    "icms-20-alc": "12921.11",
    "icms-21-alc": "13084.68",
    "icms-22-alc": "13252.43",
    "icms-23-alc": "13424.53",
    "withoutTaxes": "10336.89",
    "icms-17.5-alc": "12529.58",
    "icms-19.5-alc": "12840.86",
    "icms-20.5-alc": "13002.37",
    "icms-22.5-alc": "13337.92"
  },
  "invalidBarcodes": [
    "0000000000000"
  ],
  "activeSubstances": [
    "MEPOLIZUMABE"
  ],
  "therapeuticClass": "R3M - ANTIASMÁTICOS INIBIDORES DA INTERLEUCINA",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1010703350024",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "prescriptionRequired": true,
  "therapeuticClassCode": "R3M",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:510620110056307"